Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
YieldMax Nasdaq 100 0DTE Covered Call Strategy ETFTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $37.9 (market cap $29.19M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 1059.6× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals.

GEHCQDTY
Market Cap
$30.93B$29.19M
Volume
5,033,45117,129
Sector
HealthIncome / Options Overlay
52-Week High
$88.16$46.71
52-Week Low
$59.48$36.57
Enterprise Value
$39.39B—
Dividend Yield
0.23%—
Typical Hold Time
—64 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY trades at $38.94, down 0.36% with bearish technical signals from moving averages. The ETF maintains a consistent weekly dividend distribution strategy, with recent payments ranging from $0.19 to $0.30 per share. Technical indicators show mixed signals with RSI in neutral territory while ADX suggests weakening trend strength. The stock faces resistance at $40 with support clustered around $39.

The outlook remains cautious given bearish technical momentum and concentrated support levels. Dividend consistency provides income appeal, but technical weakness and tight trading range near current levels suggest limited near-term upside potential. Key risks include market volatility impact on covered call strategies and dependency on Nasdaq 100 performance.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.

Read more on QDTY →